Metagenomic Analysis Reveals Large‐Scale Disruptions of the Gut Microbiome in Parkinson's Disease

Author:

Metcalfe‐Roach Avril12ORCID,Cirstea Mihai S.12ORCID,Yu Adam C.3,Ramay Hena R.4,Coker Olabisi4,Boroomand Seti5,Kharazyan Faezeh5,Martino Davide6ORCID,Sycuro Laura K.47,Appel‐Cresswell Silke38,Finlay B. Brett129

Affiliation:

1. Department of Microbiology and Immunology University of British Columbia Vancouver British Columbia Canada

2. Michael Smith Laboratories University of British Columbia Vancouver British Columbia Canada

3. Pacific Parkinson's Research Centre Djavad Mowafaghian Centre for Brain Health University of British Columbia Vancouver British Columbia Canada

4. International Microbiome Centre Cumming School of Medicine University of Calgary Calgary Alberta Canada

5. Borgland Family Brain Tissue and DNA Bank Djavad Mowafaghian Centre for Brain Health University of British Columbia Vancouver British Columbia Canada

6. Department of Clinical Neurosciences Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada

7. Department of Microbiology, Immunology, and Infectious Diseases University of Calgary Calgary Alberta Canada

8. Division of Neurology Faculty of Medicine University of British Columbia Vancouver British Columbia Canada

9. Department of Biochemistry and Molecular Biology University of British Columbia Vancouver British Columbia Canada

Abstract

AbstractBackgroundParkinson's disease (PD) has been consistently linked to alterations within the gut microbiome.ObjectiveOur goal was to identify microbial features associated with PD incidence and progression.MethodsMetagenomic sequencing was used to characterize taxonomic and functional changes to the PD microbiome and to explore their relation to bacterial metabolites and disease progression. Motor and non‐motor symptoms were tracked using Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) and levodopa equivalent dose across ≤5 yearly study visits. Stool samples were collected at baseline for metagenomic sequencing (176 PD, 100 controls).ResultsPD‐derived stool samples had reduced intermicrobial connectivity and seven differentially abundant species compared to controls. A suite of bacterial functions differed between PD and controls, including depletion of carbohydrate degradation pathways and enrichment of ribosomal genes. Faecalibacterium prausnitzii‐specific reads contributed significantly to more than half of all differentially abundant functional terms. A subset of disease‐associated functional terms correlated with faster progression of MDS‐UPDRS part IV and separated those with slow and fast progression with moderate accuracy within a random forest model (area under curve = 0.70). Most PD‐associated microbial trends were stronger in those with symmetric motor symptoms.ConclusionWe provide further evidence that the PD microbiome is characterized by reduced intermicrobial communication and a shift to proteolytic metabolism in lieu of short‐chain fatty acid production, and suggest that these microbial alterations may be relevant to disease progression. We also describe how our results support the existence of gut‐first versus brain‐first PD subtypes. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Funder

Canadian Institutes of Health Research

Parkinson Canada

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3